Development of LentiVEX™ Packaging and
Producer Cell Lines for Lentivirus Manufacture
Presenter:
Corinne BranciaroliGroup Leader, CLD Viral Manufacturing,
OXGENE, a WuXi Advanced Therapies Company
Corinne joined OXGENE in 2017 and after a brief period working as Molecular Biology Scientist, moved onto cell line engineering, developing cell line platforms with enhanced characteristics for viral vector manufacture (rAAV, LVV, AdV). As a group leader of viral cell line development, Corinne continues to optimize solutions for both commercial and internal R&D projects, the main focus being development of lentivirus packaging and producer cell lines.
Prior to OXGENE, Corinne gained extensive experience in molecular biology, protein purification and immunoassays working in both academia and industry settings. Corinne holds a bachelor's degree from Universita’ degli studi dell’Aquila and a master's degree from Universita’ Politecnica delle Marche (Italy).
